Učitavanje...
Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998–2008
OBJECTIVE: Infants with chronic lung disease of infancy (CLDI) are at high risk for severe respiratory syncytial virus (RSV) illness requiring hospitalization. Palivizumab was first licensed in 1998 for the prevention of RSV disease in high-risk infants, including those with CLDI. We performed a ret...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3191114/ https://ncbi.nlm.nih.gov/pubmed/22003308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S17189 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|